Targeted copper radiation tested in kids with tough cancer
NCT ID NCT04023331
Summary
This study tested a personalized radiation therapy called 67Cu-SARTATE in children with high-risk neuroblastoma, a serious childhood cancer. The goal was to find the safest and most effective dose and see if it could help control the cancer. The trial was designed to adapt treatment for each child but was terminated after enrolling 21 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Centre
Cincinnati, Ohio, 45229, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
University of Texas Southwestern Medical Centre
Dallas, Texas, 75390, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.